Introduction

Periodontitis is an inflammatory disease of the gums destroying tooth supporting tissues characterized by periodontal pocket formation, alveolar bone resorption, and eventually tooth loss. Some of the bacteria involved in periodontitis are Aggregatibacter actinomycetemcomitans, Prevotella intermedia, Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola but the presence of bacteria alone cannot determine the type or severity of periodontitis. Host immune responses against periodontal pathogens influence the course of periodontal disease (Silva et al., 2015). Periodontitis is a multifactorial disease with several factors responsible for its severity- initiated by pathogenic bacteria, progressed by host immune response and inflammation against bacteria and modified by various environmental and genetic factors (Pietropaoli et al., 2010).  Diabetes is considered a risk factor, and advanced chronic periodontitis often coexists with poorly controlled diabetes (Choi et al., 2010). Diabetes exacerbates periodontal condition by upregulation of cytokines from monocytes/polymorphonuclear leukocytes and predisposes to chronic inflammation leading to progressive tissue breakdown and reduced tissue repair capacity. It was found that the prevalence of severe attachment loss increased with decreasing control of diabetes (Ohlrich et al., 2010)

Hyperglycemia

Hyperglycemia can result in an increased glucose concentration in saliva and gingival crevicular fluid (GCF), leading to increased proliferation of bacteria in the oral cavity (Sharma et al., 2016). In diabetic patients with persistent hyperglycemia, there is an exaggerated immuno-inflammatory response against periodontal pathogenic bacteria, which results in a more rapid and severe periodontal tissue destruction (Taylor et al., 2008 ). In hyperglycemic patients, there is an increased deposition of advanced glycation end products (AGEs) in periodontal tissues, and interactions between AGEs and their receptor (RAGE) can lead to activation of local immune responses. Altered immune responses result in an increased secretion of cytokines, increased oxidative stress, and disruption of receptor activator of nuclear factor ligand RANKL/osteoprotegerin (OPG), and all of these factors result in resorption of alveolar bone and periodontal connective tissue damage (Preshaw, Bissett et al., 2019). Study conducted by Vieira Ribeiro et al., 2011 showed that RANKL, Interferon ? (IFN?), Interleukin- 17 (IL-17), and IL-23 were elevated in type 2 diabetes patients with chronic periodontitis as compared to patients with chronic periodontitis only and a possible association was suggested. Some important factors that link periodontitis and diabetes are explained below and summarized in Figure 1.

Hyperglycemia induced destructive tissue mechanisms

Age/rage

The chemical transformation of amine-containing molecules such as proteins or nucleotides by reducing sugars results in AGEs or Maillard products (Vlassara et al., 2015). Diabetes especially when poorly controlled, increases the formation of AGEs (Lalla AMBROSIO et al., 2001). Interaction of AGE with its receptor RAGE in endothelial cells activates downstream signaling leading to hyperpermeability and enhanced expression of adhesion molecules, such as vascular cell adhesion molecule-l (VCAM-I). This interaction induces chemotaxis and an increased generation of cytokines such as tumor necrosis factor (TNF), IL-1, or IL-6 resulting in increased susceptibility to tissue destruction. Several AGEs initiate a range of cellular responses, including stimulating monocyte chemotaxis, osteoclast-induced bone resorption, the proliferation of vascular smooth muscle cells, aggregation of platelets, stimulation of secretion of collagenase, and several growth factors (Rajeev et al., 2011).

Upregulated Cytokine Production

Periodontal pathogens and their endotoxins are recognized by toll-like receptors (TLRs) on the surface of immune cells, initiating an inflammatory response. Also, AGE produced due to elevated glucose levels in diabetic patients interacts with its monocytic receptors contributing to the hyperresponsive phenotype seen in periodontitis through activation of transcription factor NF-kB, increasing gene transcription for inflammatory cytokines (Iacopino et al., 2001) . Various proinflammatory cytokines, including prostaglandin E2 (PGE2) and IL-1ß decrease the collagen synthesis by fibroblasts and influence osteoclastic bone resorption, and these cytokines in crevicular fluid and gingival tissue in patients with chronic periodontitis increased proportionally to the severity of periodontal disease (Tawfig et al., 2016). The balance between stimulatory and inhibitory cytokines and their signaling cascades determines the level of periodontal tissue loss (Graves et al., 2008).

Rankl/Opg

Increased cytokines are secreted in GCF/saliva due to inflammation, and RANKL, a ligand belonging to TNF family, is expressed by osteoblasts, activated T and B cells, and fibroblasts in response to these cytokines. RANK receptor is expressed on the surface of preosteoclasts, and osteoclasts and the secreted RANKL ligand binds directly to its cognate RANK receptor resulting in differentiation and the activation of osteoclasts that mediate bone resorption(Ochanji. et al., 2017).  Under physiological conditions, the activities of osteoclasts and osteoblasts are highly regulated and play a significant role in bone remodeling with the resorption of bone by osteoclasts followed by new bone formation by osteoblasts (Tanaka et al., 2005). However, in pathological processes, the two processes are disrupted. 

Diabetes affects osteoclast and osteoblasts in the periodontium by increasing the expression of inflammatory mediators and RANKL/ OPG ratios and by enhancing the levels of AGEs and reactive oxygen species (ROS) (Wu et al., 2015) . OPG is considered a protective factor against bone loss as it functions as a decoy receptor for RANKL and prevents RANKL binding to RANK, thereby preventing bone loss, and RANKL/RANK/OPG system is a master regulator of bone resorption (Liu , Zhang et al., 2015) . In a study by Mahamed et al. 2005, in type 1 diabetes, after A.actinomycetemcomitans inoculation, nonobese diabetic mice exhibited higher alveolar bone loss associated with significantly higher proliferation and expression of RANKL. 

Dysregulated Neutrophil Function

Neutrophils are considered the first line of defense against periodontal pathogens, and defects in neutrophil function and recruitment have been observed in diabetic patients. In type 1 diabetics with severe periodontitis, it has been shown that the peripheral blood neutrophils have reduced chemotactic and phagocytic activity when compared with non-diabetics with periodontitis(Manouchehr-Pour et al., 1981). In contrast, hyperactivity of neutrophils has also been noted. Inflammatory cytokines increase vascular permeability and recruit neutrophils into the tissue, where they release lysosomal enzymes that contribute to tissue degradation. Neutrophils from diabetic patients with periodontitis produce abnormally high levels of superoxide radicals due to hyperglycemic state and periodontitis condition, which brings about significant tissue damage compared to healthy subjects with periodontitis alone(Shetty  et al., 2008).

Oxidative Stress

Host immune cells like neutrophils release large amounts of reactive oxygen species (ROS) by NADPH oxidase complex at the site of infection that enables the immune system to cope with microorganisms by attacking the membranes of bacterial pathogens(Nguyen et al., 2017). Hyperglycemia in diabetic patients activates a particular metabolic route that involves diacylglycerol (DAG) - protein kinase C (PKC) - NADPH oxidase and culminates in the generation of ROS (Volpe et al., 2018). Oxidative stress occurs when there is a disturbance in the balance between the production of ROS and antioxidant defenses, which in turn lead to tissue injury in numerous inflammatory diseases, including periodontitis by causing damage to host biological macromolecules - lipids, proteins, nucleic acids, and carbohydrates(Betteridge et al., 2000). In a study, it has been reviewed that oxidative capacity in periodontitis patients is contradictory with some studies showing leukocytes from patients with periodontitis are exhausted and have a low oxidation activity, other studies pointing toward higher production of ROS by leukocytes from periodontitis patients(Celec et al., 2017).

Hyperlipidemia

Hyperlipidemia can arise from a high-fat diet, metabolic disorders such as type 2 diabetes, or can be produced in response to infectious processes (Fentoglu et al., 2008).  Defects in insulin action and hyperglycemia could lead to changes in plasma lipoproteins and the lipoprotein abnormalities commonly present in type 2 diabetes, including hypertriglyceridemia and reduced plasma high-density lipoprotein (HDL) cholesterol (Goldberg et al., 2001). Cytokines such as TNF-a and IL-1ß produced on exposure to periodontal pathogens/endotoxin result in elevated levels of free fatty acids, low-density lipoprotein (LDL), and triglyceride through enhanced hepatic lipogenesis, increased synthesis or reduced clearance of triglyceride, and reduced clearance of LDL due to reductions in lipoprotein lipase activity(Lutfioglu et al., 2017). In addition, hyperlipidemia may be associated with the progressive periodontal disease through polymorphonuclear priming and hyperfunction, causing increased neutrophil respiratory bursts leading to oxidative stress. Lei et al., 2013 study found that hyperlipidemia may lead to more severe periodontal bone loss by impairing the immune response to P. gingivalis challenge by altering pattern recognition receptor (PRRs) expression in macrophages leading to an inhibited cytokine network response and decreased bacterial clearance. In a study conducted in 2014, it was found that LDL-cholesterol was increased in chronic periodontitis patients than in healthy subjects in contrast HDL-cholesterol levels were increased in healthy subjects than in subjects with chronic periodontitis(Akkaloori et al., 2014).

Defective Collagen Synthesis

Collagen is an important component of the periodontium and the synthesis, maturation, and homeostasis of collagen are affected by the glucose level(Surlin et al., 2014). Proteins become glycated in high glucose environment to form AGE which accumulates in the periodontium, causing changes in the cells and extracellular matrix (ECM) components. Collagen produced by fibroblasts under these conditions is susceptible to rapid degradation by matrix metalloproteinase (MMP) enzymes, such as collagenase, the production of which is significantly higher in diabetes condition ³². Elevated GCF collagenase degrades newly synthesized collagen fibers and decreases gingival fibroblast collagen synthesis(Ryan et al., 2003). Glycation of the collagen fibers also reduces its solubility, affecting remodeling and healing(Grover et al., 2013).

Antimicrobial Peptides

Antimicrobial peptides are part of innate immune responses and components of first line of defense against periodontal pathogens. A study conducted in 2019 showed that levels of cathelicidin and human neutrophil peptides (HNPs) 1-3 were increased in patients with chronic periodontitis and type 2 diabetes compared with controls(Zainab et al., 2019). Another study showed that beta-defensin 1 level in GCF was reduced in periodontitis with type 2 diabetes (Yilmaz et al., 2018). One of the reasons for reducing defensins could be explained by the inhibition of P38 mitogen-activated protein kinases (p38MAPK) signaling, resulting from increased AGE formation in diabetic patients(Lanet al., 2011).

Conclusion

Diabetes and periodontitis are two widespread chronic inflammatory conditions.  In diabetic patients, hyperglycaemia stimulates the immune system's cells to release inflammatory cytokines. Elevated inflammatory mediators alter the activity of leukocytes and osteoblasts-osteoclasts, and the tissue remodeling process. Since diabetes and periodontitis are interlinked, it is imperative to keep diabetes under control while considering treatment for periodontitis.

Author contribution

Harini Venkata Subbiah, Polani Ramesh Babu conceived of the presented idea Usha Subbiah, Daniel Rajendran T, Vinod Kumar P encouraged and supervised the findings of this work. All authors discussed the results and contributed to the final manuscript.

References

Akkaloori A, Parthasarathi P, Anjum MS, Gadde P, Mocherla M, Rao Y. Association between chronic periodontal disease and cardiovascular risk factor hyperlipidemia. J Dr NTR Univ Heal Sci. 2014;3(4):249.

https://doi.org/10.4103/2277-8632.146628

Betteridge DJ. What is oxidative stress? Metabolism. 2000;49(2):3-8.

https://doi.org/10.1016/S0026-0495(00)80077-3

Celec P. Oxidative stress and antioxidants in the diagnosis and therapy of periodontitis. Front Physiol. 2017;8:1055.

https://doi.org/10.3389/fphys.2017.01055

Choi Y-H, McKeown RE, Mayer-Davis EJ, Liese AD, Song K-B, Merchant AT. Association between periodontitis and impaired fasting glucose and diabetes. Diabetes Care. 2011;34(2):381-386.

https://doi.org/10.2337/dc10-1354

Fentoglu O, Bozkurt FY. The bi-directional relationship between periodontal disease and hyperlipidemia. Eur J Dent. 2008;2(02):142-149.

https://doi.org/10.1055/s-0039-1697370

Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965-971.

https://doi.org/10.1210/jcem.86.3.7304

Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585-1591.

https://doi.org/10.1902/jop.2008.080183

Grover HS, Luthra S. Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease. J Indian Soc Periodontol. 2013;17(3):292.

https://doi.org/10.4103/0972-124X.115642

Iacopino AM. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol. 2001;6(1):125-137.

https://doi.org/10.1902/annals.2001.6.1.125

Lalla R V, D'AMBROSIO JA. Dental management considerations for the patient with diabetes mellitus. J Am Dent Assoc. 2001;132(10):1425-1432.

https://doi.org/10.14219/jada.archive.2001.0059

Lan C-CE, Wu C-S, Huang S-M, et al. High-glucose environment inhibits p38MAPK signaling and reduces human β-3 expression in keratinocytes. Mol Med. 2011;17(7):771-779.

https://doi.org/10.2119/molmed.2010.00091

Lei L, Li H, Yan F, Xiao Y. Hyperlipidemia impaired innate immune response to periodontal pathogen Porphyromonas gingivalis in apolipoprotein E knockout mice. PLoS One. 2013;8(8):e71849.

https://doi.org/10.1371/journal.pone.0071849

Liu W, Zhang X. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues. Mol Med Rep. 2015;11(5):3212-3218.

https://doi.org/10.3892/mmr.2015.3152

Lutfioglu M, Aydogdu A, Atabay VE, Sakallioglu EE, Avci B. Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia. Braz Oral Res. 2017;31.

https://doi.org/10.1590/1807-3107bor-2017.vol31.0110

Mahamed DA, Marleau A, Alnaeeli M, et al. G (−) Anaerobes-Reactive CD4+ T-Cells Trigger RANKL-Mediated Enhanced Alveolar Bone Loss in Diabetic NOD Mice. Diabetes. 2005;54(5):1477-1486.

https://doi.org/10.2337/diabetes.54.5.1477

Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol. 1981;52(8):410-415.

https://doi.org/10.1902/jop.1981.52.8.410

MR P, Surlin P, Rauten AM, Dragomir L, Olteanu M. Histological analysis of collagen fibers in patients with diabetes mellitus and periodontal disease. J Cytol Histol S. 2014;4:2.

https://doi.org/10.4172/2157-7099.S4-008

Nguyen GT, Green ER, Mecsas J. Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance. Front Cell Infect Microbiol. 2017;7:373.

https://doi.org/10.3389/fcimb.2017.00373

Ochanji AA, Matu NK, Mulli TK. Association of salivary RANKL and osteoprotegerin levels with periodontal health. Clin Exp Dent Res. 2017;3(2):45-50.

https://doi.org/10.1002/cre2.49

Ohlrich EJ, Cullinan MP, Leichter JW. Diabetes, periodontitis, and the subgingival microbiota. J Oral Microbiol. 2010;2(1):5818.

https://doi.org/10.3402/jom.v2i0.5818

Pietropaoli D, Tatone C, D'Alessandro AM, Monaco A. Possible involvement of advanced glycation end products in periodontal diseases. Int J Immunopathol Pharmacol. 2010;23(3):683-691.

https://doi.org/10.1177/039463201002300301

Preshaw PM, Bissett SM. Periodontitis and diabetes. Br Dent J. 2019;227(7):577-584.

https://doi.org/10.1038/s41415-019-0794-5

Rajeev K, Karthika R, Mythili R, Krishnan V, Nirmal M. Role of receptors of advanced glycation end-products (RAGE) in type 2 diabetic and non-diabetic individuals with chronic periodontal disease: an immunohistochemical study. J Investig Clin Dent. 2011;2(4):287-292.

https://doi.org/10.1111/j.2041-1626.2011.00079.x

Ryan ME, Carnu O, Kamer A. The influence of diabetes on the periodontal tissues. J Am Dent Assoc. 2003;134:34S-40S.

https://doi.org/10.14219/jada.archive.2003.0370

Sharma M, Jindal R, Siddiqui MA, Wangnoo SK. Diabetes and Periodontitis: A medical perspective. J Int Clin Dent Res Organ. 2016;8(1):3.

https://doi.org/10.4103/2231-0754.176244

Shetty N, Thomas B, Ramesh A. Comparison of neutrophil functions in diabetic and healthy subjects with chronic generalized periodontitis. J Indian Soc Periodontol. 2008;12(2):41.

https://doi.org/10.4103/0972-124X.44089

Silva N, Abusleme L, Bravo D, et al. Host response mechanisms in periodontal diseases. J Appl Oral Sci. 2015;23(3):329-355.

https://doi.org/10.1590/1678-775720140259

Tanaka Y, Nakayamada S, Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets-Inflammation Allergy. 2005;4(3):325-328.

https://doi.org/10.2174/1568010054022015

Tawfig N. Proinflammatory cytokines and periodontal disease. J Dent Probl Solut. 2016;3(1):12-17.

https://doi.org/10.17352/2394-8418.000026

Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis. 2008;14(3):191-203.

https://doi.org/10.1111/j.1601-0825.2008.01442.x

Vieira Ribeiro F, de Mendonça AC, Santos VR, Bastos MF, Figueiredo LC, Duarte PM. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2011;82(8):1187-1196.

https://doi.org/10.1902/jop.2011.100643

Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep. 2014;14(1):1-10.

https://doi.org/10.1007/s11892-013-0453-1

Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):1-9.

https://doi.org/10.1038/s41419-017-0135-z

Wu Y-Y, Xiao E, Graves DT. Diabetes mellitus related bone metabolism and periodontal disease. Int J Oral Sci. 2015;7(2):63-72.

https://doi.org/10.1038/ijos.2015.2

Yilmaz D, Caglayan F, Buber E, et al. Gingival crevicular fluid levels of human beta-defensin-1 in type 2 diabetes mellitus and periodontitis. Clin Oral Investig. 2018;22(5):2135-2140.

https://doi.org/10.1007/s00784-018-2469-z

Zainab AJAA, Ashish N, Ragnath V. Salivary Levels of Antimicrobial Peptides in Chronic Periodontitis Patients with Type 2 Diabetes. J Int Acad Periodontol. 2019;21(1):36-44.